# Seguridad Health Measures Implementation Guide

# Chapter 1: Introduction



# Introduction

<span style="font-size: 11.0pt;">Thank you joining Seguridad’s measurement system, Choose My Pharmacy™. Our vision is to help patients choose pharmacies in a transparent, quality-focused manner. We believe choosing a pharmacy is about more than convenience – it’s about high-quality care versus a commodity. We can achieve this vision through our mission to provide a patient-centric evaluation of pharmacies to improve patient outcomes. We believe a community pharmacy should have a star rating or measurement system developed for evaluating pharmacies using measures designed for community pharmacies. </span>

<span style="font-size: 11.0pt;">Our core values are listed below and represent who we are and what we do for pharmacy practice, healthcare quality, and patient care. We want to help pharmacists be pharmacists and ensure the right patient gets the right drug at the right dose through the right route at the right time for the right reason. Everything we do focuses on helping pharmacies optimize patient care and improve outcomes. </span>

<span style="font-size: 11.0pt;"> </span>

**<span style="font-size: 11.0pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;">Core Values of Seguridad, Inc</span>**

***<span style="font-size: 11.0pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;">Safety</span>***

<span style="font-size: 11.0pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;">Advance patient safety in pharmacy practice.</span>

***<span style="font-size: 11.0pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;">Education</span>***

<span style="font-size: 11.0pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;">Anyone will be able to understand *why* pharmacy quality is essential and *how* to use the information.</span>

***<span style="font-size: 11.0pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;">Improvement</span>***

<span style="font-size: 11.0pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;">Pharmacies will improve the quality of care delivered through measurement science.</span>

***<span style="font-size: 11.0pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;">Entrusted</span>***

<span style="font-size: 11.0pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;">A trusted source of pharmacy quality for decision-makers.</span>

***<span style="font-size: 11.0pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;">Empowered</span>***

<span style="font-size: 11.0pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;">Pharmacies will be able to demonstrate a role in high-quality healthcare.</span>

***<span style="font-size: 11.0pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;">Well-Being</span>***

<span style="font-size: 11.0pt; mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin; color: black; mso-themecolor: text1;">Healthy through fiscal accountability and a culture of excellence</span>

<span style="font-size: 11.0pt;"><span style="mso-spacerun: yes;"> </span></span>

<span style="font-size: 11.0pt;">We look forward to helping you become a “Five-Star Pharmacy.” Feel free to contact us at **healthequity@choosemypharmacy.com** if you have any questions or if we can help you in any way.</span>

# Chapter 2: Implementation



# Implementation

There are currently eleven (11) Seguridad Health Measures® as part of the Choose My Pharmacy® measurement system summarized in chapter 3. The full measure specifications may be found in chapter 4.

A measurement system is a report card, or star rating, evaluating the performance of the stakeholder – in this case, community pharmacies. The pharmacy is encouraged to implement a myriad of diverse services to improve patient outcomes and lower healthcare cost. Choose My Pharmacy® is how well the pharmacy performs in these goals.

Every pharmacy that participates in Choose My Pharmacy® shares standard, de-identified data to Seguridad, Inc. Seguridad, Inc uses proprietary calculations and analytics to produce a customized report card for the pharmacy. Each pharmacy receives a calendar year score, reported with four quarterly report cards. Overtime, pharmacies will be able to track progress year-over-year on Seguridad Health Measures® - from the current core set to future measures in development.

Seguridad leverages a HIPAA-Secure survey platform, JotForm, to help collect pharmacy information. Each pharmacy pharmacist-in-charge (PIC) will:

<div class="page" id="bkmrk-receive-a-business-a" title="Page 3"><div class="page" title="Page 3"><div class="layoutArea"><div class="column">1. Receive a Business Associate Agreement (BAA) between the pharmacy and Seguridad. This form will be pre-populated with pharmacy specific details and a digital signature is requested.
2. The PIC will receive the Seguridad PIC On-Boarding Survey after execution of the BAA.
3. The PIC will receive the Seguridad Data Request after the PIC On-Boarding Survey is complete.  
    a. This will be requested on a quarterly basis to update measure results.
4. The PIC will receive a link for the Employee Survey. This is to be completed by each individual involved with the fill and dispensing of medications.
5. Once all data is collected, Seguridad will provide a Choose My Pharmacy® Health Measures Report Card to the pharmacy.

</div></div></div></div>

# Chapter 3: Choose My Pharmacy® Core Measure Set



# Seguridad Health Measures®

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-title-description-pe" style="border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150">**<span style="font-size: 11.0pt;">Title</span>**

</td><td style="width: 247.5pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330">**<span style="font-size: 11.0pt;">Description</span>**

</td><td style="width: 107.75pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144">**<span style="font-size: 11.0pt;">Performance</span>**

</td></tr><tr style="mso-yfti-irow: 1;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Assessment of Renal Function in Older Adults</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of patients aged 65 years and older with a serum creatine on file at the pharmacy during the measurement year</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 2;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Assessment of Weights in Pediatrics</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of pediatric patients (17 years and less) with an updated weight during the measurement year</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 3;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Known Allergy Status</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of patient records with documented allergy status, including ‘no known drug allergies’.</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 4;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Medication Indication</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of electronic prescriptions with *prescriber-reported* indication based on International Classification of Disease – 10</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144">**<span style="font-size: 11.0pt;">This is a reporting measure only</span>**

</td></tr><tr style="mso-yfti-irow: 5;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Electronic Care Plan Accessibility</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Possession of e-care plan with appropriate training</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 6;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Point of Care Testing Structure</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Possession of a CLIA-waiver in the pharmacy.</span>

<span style="font-size: 11.0pt;"> </span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 7;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Employee Vaccination Rate</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of employees in a pharmacy that are vaccinated for influenza and COVID-19.</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 8;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Advanced Pharmacy Technicians</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of pharmacy technicians with advance training</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 9;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Improving Pain Management Safety</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of households at risk for opioid adverse event with naloxone available</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 10;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Improving Diabetes Safety</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of patients with high-risk diabetes with glucagon available.</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 11; mso-yfti-lastrow: yes;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Identify Social Determinants of Health</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of patients with documented demographic information.</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr></tbody></table>

# Chapter 4: Choose My Pharmacy® Measure Specifications



# Assessment of Renal Function in Older Adults

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-title-assessment-of-" style="width: 795px; border-collapse: collapse; border: none; height: 1623px;" width="890"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 10.0pt;"><td style="width: 121.555px; border: 1pt solid windowtext; padding: 0in 5.4pt; height: 10pt;" valign="top">Title

</td><td style="width: 673.094px; border-top: 1pt solid windowtext; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-image: initial; border-left: none; padding: 0in 5.4pt; height: 10pt;" valign="top">Assessment of Renal Function in Older Adults

</td></tr><tr style="mso-yfti-irow: 1; height: 40.15pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 40.15pt;" valign="top">Description

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 40.15pt;" valign="top">Percent of patients aged 65 years and older with a serum creatine on file at the pharmacy during the measurement year

A higher score is better

</td></tr><tr style="mso-yfti-irow: 2; height: 30.1pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 30.1pt;" valign="top">Rationale

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 30.1pt;" valign="top">Older adults have diminished renal function and many medications need to be adjusted based on renal excretion. This measure assesses whether the pharmacy has collected the laboratory information required to assess renal function.

</td></tr><tr style="mso-yfti-irow: 3; height: 173.2pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 173.2pt;" valign="top">Logic Model

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 173.2pt;" valign="top">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/RLZimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/RLZimage.png)

This measure ensures the pharmacy has the salient information (serum creatine) to ensure patient specific dosing.

</td></tr><tr style="mso-yfti-irow: 4; height: 10.0pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 10pt;" valign="top">Level of Analysis

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 10pt;" valign="top">Pharmacy (Patient)

</td></tr><tr style="mso-yfti-irow: 5; height: 9.5pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 9.5pt;" valign="top">Data Source

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 9.5pt;" valign="top">Pharmacy Data

</td></tr><tr style="mso-yfti-irow: 6; height: 20.05pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 20.05pt;" valign="top">Denominator Statement

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 20.05pt;" valign="top">All patients aged 65 years or older that received a medication during the measurement year.

</td></tr><tr style="mso-yfti-irow: 7; height: 30.1pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 30.1pt;" valign="top">Denominator Calculation

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 30.1pt;" valign="top"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>1. All individuals in the pharmacy

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>2. All individuals aged 65 or older at the beginning of the measurement year

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>3. Must have received a medication during the measurement year

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>4. Remove an individual with exclusion criteria

</td></tr><tr style="mso-yfti-irow: 8; height: 20.05pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 20.05pt;" valign="top">Denominator Exclusions

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 20.05pt;" valign="top">Any patient only receiving an immunization at the pharmacy

Any non-human patients (e.g., cats, dogs, clinics, office-use, etc)

</td></tr><tr style="mso-yfti-irow: 9; height: 30.1pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 30.1pt;" valign="top">Denominator Exclusion Rationale

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 30.1pt;" valign="top">Many pharmacies may host immunization clinics and only interact with a patient during these visits. As immunizations do not need to be renally adjusted, assessment of renal function is not a required (valid) assessment.

Pharmacies may provide care to pets or other veterinarian needs, or for office-use. This patient profiles should be excluded from the measure calculation.

</td></tr><tr style="mso-yfti-irow: 10; height: 20.05pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 20.05pt;" valign="top">Numerator Statement

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 20.05pt;" valign="top">Individuals from the denominator with a serum creatine drawn during the measurement year

</td></tr><tr style="mso-yfti-irow: 11; height: 30.1pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 30.1pt;" valign="top">Numerator Calculation

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 30.1pt;" valign="top"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>1. Identify number of individuals with serum creatine recorded

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>2. Identify number of individuals with serum creatine updated during the measurement year

</td></tr><tr style="mso-yfti-irow: 12; height: 30.1pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 30.1pt;" valign="top">Seguridad Measure Specification Process

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 30.1pt;" valign="top">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/Paeimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/Paeimage.png)

<span style="mso-no-proof: yes;">  
</span>

</td></tr><tr style="mso-yfti-irow: 13; height: 30.1pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 30.1pt;" valign="top">Data Stratification

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 30.1pt;" valign="top">The measure rate will be reported as a percent of patients within a single pharmacy.

If available and feasible, measure rate will be reported by type of pharmacy (e.g., health-system, community, specialty, mail-order, long-term care).

If available and feasible, measure rate will be reported by line of business (pharmacy Medicare rate, pharmacy Medicaid rate, pharmacy Commercial rate, and pharmacy uninsured rate).

Risk adjustment will be applied when available.

</td></tr><tr style="mso-yfti-irow: 14; height: 10.0pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 10pt;" valign="top">Value Sets

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 10pt;" valign="top">The value set *Seguridad - CMP Immunizations* will be used to support the exclusion criteria.

</td></tr><tr style="mso-yfti-irow: 15; height: 10.0pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 10pt;" valign="top">Future Iterations

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 10pt;" valign="top">Many pharmacy measures are designed as structure or process. Future goals of this concept include measures focused on appropriate dosing based on renal function and assessment of all patients.

</td></tr><tr style="mso-yfti-irow: 16; mso-yfti-lastrow: yes; height: 19.55pt;"><td style="width: 121.555px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 19.55pt;" valign="top">Harmonization<sup>1</sup>

</td><td style="width: 673.094px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 19.55pt;" valign="top">Payors: N/A

Providers: N/A

</td></tr></tbody></table>

1\. Measures that have either the same target populations (denominator) or the same measure focus (numerators) may be considered related, whereas measures that have the same targeted population (denominator) and same measure focus (numerator), are considered competing measures. Measures being developed should be harmonized, where feasible, to previously established measures to decrease measure burden. Choose My Pharmacy measures are developed for pharmacy evaluation, which is a novel area for measurement science, no current measure evaluates this level of analysis. Choose My Pharmacy measures will be harmonized to the extent possible, recognizing different levels of analysis have different data elements, and instead the focus will be to vertically integrate the Choose My Pharmacy measures with other measurement systems and measures.

# Assessment of Weights in Pediatrics

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-title-assessment-of-" style="width: 667.25pt; border-collapse: collapse; border: none; height: 1198.26px;" width="890"><tbody><tr style="height: 23.5069px;"><td style="width: 156.062px; border: 1pt solid windowtext; padding: 0in 5.4pt; height: 23.5069px;" valign="top" width="154">Title

</td><td style="width: 733.599px; border-top: 1pt solid windowtext; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-image: initial; border-left: none; padding: 0in 5.4pt; height: 23.5069px;" valign="top" width="736">Assessment of Weights in Pediatrics

</td></tr><tr style="height: 68.2986px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 68.2986px;" valign="top" width="154">Description

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 68.2986px;" valign="top" width="736">Percent of pediatric patients (17 years and less) with an updated weight during the measurement year

A higher score is better

</td></tr><tr style="height: 45.9028px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 45.9028px;" valign="top" width="154">Rationale

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 45.9028px;" valign="top" width="736">Most pediatric prescriptions are weight-based and the pharmacy should be checking the dose prior to dispensing.

</td></tr><tr style="height: 260.365px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 260.365px;" valign="top" width="154">Logic Model

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 260.365px;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/Rzmimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/Rzmimage.png)<span style="mso-no-proof: yes;"></span>

This measure ensures the pharmacy has the salient information (weight) to ensure patient specific dosing.

</td></tr><tr style="height: 23.5069px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 23.5069px;" valign="top" width="154">Level of Analysis

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 23.5069px;" valign="top" width="736">Pharmacy (Patient)

</td></tr><tr style="height: 23.5069px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 23.5069px;" valign="top" width="154">Data Source

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 23.5069px;" valign="top" width="736">Pharmacy Data

</td></tr><tr style="height: 45.9028px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 45.9028px;" valign="top" width="154">Denominator Statement

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 45.9028px;" valign="top" width="736">All patients 17 years and less that received a medication at the pharmacy during the measurement year

</td></tr><tr style="height: 68.2986px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 68.2986px;" valign="top" width="154">Denominator Calculation

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 68.2986px;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>1. All patients in the pharmacy

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>2. All patients age 17 or less during the measurement year

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>3. Apply exclusion criteria

</td></tr><tr style="height: 45.9028px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 45.9028px;" valign="top" width="154">Denominator Exclusions

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 45.9028px;" valign="top" width="736">Any patient only receiving an immunization at the pharmacy

Any non-human patients (e.g., cats, dogs, clinics, office-use, etc)

</td></tr><tr style="height: 113.09px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 113.09px;" valign="top" width="154">Denominator Exclusion Rationale

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 113.09px;" valign="top" width="736">Many pharmacies may host immunization clinics and only interact with a patient during these visits. As immunizations do not need to be weight-based, assessment of weight is not a required (valid) assessment.

Pharmacies may provide care to pets or other veterinarian needs, or for office-use. This patient profiles should be excluded from the measure calculation.

</td></tr><tr style="height: 45.9028px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 45.9028px;" valign="top" width="154">Numerator Statement

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 45.9028px;" valign="top" width="736">Individuals from the denominator with a weight (pounds) during the measurement year

</td></tr><tr style="height: 45.9028px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 45.9028px;" valign="top" width="154">Numerator Calculation

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 45.9028px;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Identify number of individuals with a weight recorded in the pharmacy record.

</td></tr><tr style="height: 68.2986px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 68.2986px;" valign="top" width="154">Seguridad Measure Specification Process

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 68.2986px;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/nNuimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/nNuimage.png)

<span style="mso-no-proof: yes;">  
</span>

</td></tr><tr style="height: 202.674px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 202.674px;" valign="top" width="154">Data Stratification

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 202.674px;" valign="top" width="736">The measure rate will be reported as percent of patients within a single pharmacy.

If available and feasible, measure rate will be reported by type of pharmacy (e.g., health-system, community, specialty, mail-order, long-term care).

If available and feasible, measure rate will be reported by line of business (pharmacy Medicare rate, pharmacy Medicaid rate, pharmacy Commercial rate, and pharmacy uninsured rate).

Risk adjustment will be applied when available.

</td></tr><tr style="height: 23.5069px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 23.5069px;" valign="top" width="154">Value Sets

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 23.5069px;" valign="top" width="736">The value set *Seguridad - CMP Immunizations* will be used to support the exclusion criteria.

</td></tr><tr style="height: 45.9028px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 45.9028px;" valign="top" width="154">Future Iterations

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 45.9028px;" valign="top" width="736">Many pharmacy measures are designed as structure or process. Future goals of this concept include measures focused on appropriate dosing based on weight and assessment of all patients.

</td></tr><tr style="height: 47.7865px;"><td style="width: 156.062px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 47.7865px;" valign="top" width="154">Harmonization<sup>1</sup>

</td><td style="width: 733.599px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 47.7865px;" valign="top" width="736">Payors: N/A

Providers: N/A

</td></tr></tbody></table>

1\. Measures that have either the same target populations (denominator) or the same measure focus (numerators) may be considered related, whereas measures that have the same targeted population (denominator) and same measure focus (numerator), are considered competing measures. Measures being developed should be harmonized, where feasible, to previously established measures to decrease measure burden. Choose My Pharmacy measures are developed for pharmacy evaluation, which is a novel area for measurement science, no current measure evaluates this level of analysis. Choose My Pharmacy measures will be harmonized to the extent possible, recognizing different levels of analysis have different data elements, and instead the focus will be to vertically integrate the Choose My Pharmacy measures with other measurement systems and measures.

# Known Allergy Status

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-title-known-allergy-" style="width: 667.25pt; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;" width="890"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Title

</td><td style="width: 551.7pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Known Allergy Status

</td></tr><tr style="mso-yfti-irow: 1; height: 40.15pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 40.15pt;" valign="top" width="154">Description

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 40.15pt;" valign="top" width="736">Percent of patient records with documented allergy status, including ‘no known drug allergies’.

A higher rate is better.

</td></tr><tr style="mso-yfti-irow: 2; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Community pharmacies are the last step prior to a patient receiving a medication and last chance to verify drug allergies.

</td></tr><tr style="mso-yfti-irow: 3; height: 173.2pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="154">Logic Model

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/DEpimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/DEpimage.png)

<span style="mso-no-proof: yes;">  
</span>

This measure ensures the pharmacy has the salient information (allergy history) to ensure patient specific dosing.

</td></tr><tr style="mso-yfti-irow: 4; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Level of Analysis

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Pharmacy (Patient)

</td></tr><tr style="mso-yfti-irow: 5; height: 9.5pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="154">Data Source

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="736">Pharmacy Data

</td></tr><tr style="mso-yfti-irow: 6; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">All individuals dispensed a prescription from the pharmacy during a measurement year

</td></tr><tr style="mso-yfti-irow: 7; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>1. Identify all prescriptions in a measurement year

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>2. Identify all unique patients from the prescriptions

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>3. Apply exclusions

</td></tr><tr style="mso-yfti-irow: 8; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Exclusions

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Any non-human patients (e.g., cats, dogs, clinics, office-use, etc)

</td></tr><tr style="mso-yfti-irow: 9; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Exclusion Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Pharmacies may provide care to pets or other veterinarian needs, or for office-use. This patient profiles should be excluded from the measure calculation.

</td></tr><tr style="mso-yfti-irow: 10; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Numerator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Individuals from the denominator with documented allergy status on record

</td></tr><tr style="mso-yfti-irow: 11; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Numerator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Number of individuals from the denominator with documented allergy

</td></tr><tr style="mso-yfti-irow: 12; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Seguridad Measure Specification Process

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/bAOimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/bAOimage.png)

<span style="mso-no-proof: yes;">  
</span>

</td></tr><tr style="mso-yfti-irow: 13; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Data Stratification

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">The measure rate will be reported as percent of patients within a single pharmacy.

If available and feasible, measure rate will be reported by type of pharmacy (e.g., health-system, community, specialty, mail-order, long-term care).

If available and feasible, measure rate will be reported by line of business (pharmacy Medicare rate, pharmacy Medicaid rate, pharmacy Commercial rate, and pharmacy uninsured rate).

Risk adjustment will be applied when available.

</td></tr><tr style="mso-yfti-irow: 14; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Value Sets

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">No value set is required for the calculation of this measure.

</td></tr><tr style="mso-yfti-irow: 15; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Future Iterations

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Many pharmacy measures are designed as structure or process. Future goals of this concept include measures focused on updating the allergy status on an annual basis.

</td></tr><tr style="mso-yfti-irow: 16; mso-yfti-lastrow: yes; height: 19.55pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="154">Harmonization<sup>1</sup>

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="736">Payors: N/A

Providers: N/A

</td></tr></tbody></table>

1\. Measures that have either the same target populations (denominator) or the same measure focus (numerators) may be considered related, whereas measures that have the same targeted population (denominator) and same measure focus (numerator), are considered competing measures. Measures being developed should be harmonized, where feasible, to previously established measures to decrease measure burden. Choose My Pharmacy measures are developed for pharmacy evaluation, which is a novel area for measurement science, no current measure evaluates this level of analysis. Choose My Pharmacy measures will be harmonized to the extent possible, recognizing different levels of analysis have different data elements, and instead the focus will be to vertically integrate the Choose My Pharmacy measures with other measurement systems and measures.

# Medication Indication

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-title-medication-ind" style="width: 667.25pt; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;" width="890"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Title

</td><td style="width: 551.7pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Medication Indication

</td></tr><tr style="mso-yfti-irow: 1; height: 40.15pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 40.15pt;" valign="top" width="154">Description

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 40.15pt;" valign="top" width="736">Percent of electronic prescriptions with *prescriber-reported* indication based on International Classification of Disease – 10

**This is a reporting measure only**

</td></tr><tr style="mso-yfti-irow: 2; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Pharmacies ensure the right patient gets the right drug at the right time for the right reason. This measure will help to evaluate the right reason.

Caveats: This measure is not for performance evaluation. Pharmacists may not diagnosis patients (by entering patient-reported diagnosis in the pharmacy system). This measure will evolve over time to ensure every prescription has an indication and said indication is correct.

</td></tr><tr style="mso-yfti-irow: 3; height: 173.2pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="154">Logic Model

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/pDmimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/pDmimage.png)

<span style="mso-no-proof: yes;">  
</span>

This measure is establishing the need pharmacies have for an indication on every prescription. Currently, regulatory barriers exist that prevents the measure from being ‘Every Medication Has an Indication’ however, this measure is headed in that direction.

</td></tr><tr style="mso-yfti-irow: 4; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Level of Analysis

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Pharmacy (Prescription)

</td></tr><tr style="mso-yfti-irow: 5; height: 9.5pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="154">Data Source

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="736">Pharmacy Data

</td></tr><tr style="mso-yfti-irow: 6; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">All prescriptions electronically submitted to the pharmacy during a measurement year

</td></tr><tr style="mso-yfti-irow: 7; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>1. Identify all prescriptions in a pharmacy

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>2. Identify all new prescriptions denoted as refill number 0

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>3. Identify all new prescriptions with source field (NCPDP = electronic)

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>4. Apply exclusion criteria

</td></tr><tr style="mso-yfti-irow: 8; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Exclusions

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Any electronic prescription that was canceled by the prescriber.

Any non-human patients (e.g., cats, dogs, clinics, office-use, etc)

</td></tr><tr style="mso-yfti-irow: 9; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Exclusion Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Canceled prescriptions were never filled and confirmed to not be valid prescriptions

Pharmacies may provide care to pets or other veterinarian needs, or for office-use. This patient profiles should be excluded from the measure calculation.

</td></tr><tr style="mso-yfti-irow: 10; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Numerator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Percent of electronic prescriptions with prescriber reported ICD-10

</td></tr><tr style="mso-yfti-irow: 11; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Numerator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Number of prescriptions with supplied ICD-10

</td></tr><tr style="mso-yfti-irow: 12; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Seguridad Measure Specification Process

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/Zu5image.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/Zu5image.png)

<span style="mso-no-proof: yes;">  
</span>

</td></tr><tr style="mso-yfti-irow: 13; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Data Stratification

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">The measure rate will be reported as pharmacy.

If available and feasible, measure rate will be reported by type of pharmacy (e.g., health-system, community, specialty, mail-order, long-term care).

If available and feasible, measure rate will be reported by line of business (pharmacy Medicare rate, pharmacy Medicaid rate, pharmacy Commercial rate, and pharmacy uninsured rate).

Risk adjustment will be applied when available.

</td></tr><tr style="mso-yfti-irow: 14; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Value Sets

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">No value set is required for the calculation of this measure.

</td></tr><tr style="mso-yfti-irow: 15; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Future Iterations

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Many pharmacy measures are designed as structure or process. Future goals of this concept include measures focused ensuring all prescriptions have an indication and that the indication and medication are appropriate.

</td></tr><tr style="mso-yfti-irow: 16; mso-yfti-lastrow: yes; height: 19.55pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="154">Harmonization<sup>1</sup>

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="736">Payors: N/A

Providers: This measure is similar to the CMS SNF measure ensuring all medications have an indication.

</td></tr></tbody></table>

1\. Measures that have either the same target populations (denominator) or the same measure focus (numerators) may be considered related, whereas measures that have the same targeted population (denominator) and same measure focus (numerator), are considered competing measures. Measures being developed should be harmonized, where feasible, to previously established measures to decrease measure burden. Choose My Pharmacy measures are developed for pharmacy evaluation, which is a novel area for measurement science, no current measure evaluates this level of analysis. Choose My Pharmacy measures will be harmonized to the extent possible, recognizing different levels of analysis have different data elements, and instead the focus will be to vertically integrate the Choose My Pharmacy measures with other measurement systems and measures.

# Electronic Care Plan Accessibility

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-title-electronic-car" style="width: 667.25pt; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;" width="890"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Title

</td><td style="width: 551.7pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Electronic Care Plan Accessibility

</td></tr><tr style="mso-yfti-irow: 1; height: 15.7pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 15.7pt;" valign="top" width="154">Description

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 15.7pt;" valign="top" width="736">Possession of e-care plan with appropriate training

A higher score is better

</td></tr><tr style="mso-yfti-irow: 2; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Clinical documentation is required to validate actions occurred and provide patient care notes from one provider to another.

</td></tr><tr style="mso-yfti-irow: 3; height: 173.2pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="154">Logic Model

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/kzoimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/kzoimage.png)

<span style="mso-no-proof: yes;">  
</span>

This measure ensures clinical documentation of patient encounters at the pharmacy. If it isn’t document, it didn’t happen. The E-Care Plan Accessibility measure creates the structure for future process, outcome, and patient-reported measures.

</td></tr><tr style="mso-yfti-irow: 4; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Level of Analysis

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Pharmacy (Nominal and Structure)

</td></tr><tr style="mso-yfti-irow: 5; height: 9.5pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="154">Data Source

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="736">Survey

</td></tr><tr style="mso-yfti-irow: 6; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">This measure is a structure-based measure evaluate a nominal endpoint. The denominator is the pharmacy.

</td></tr><tr style="mso-yfti-irow: 7; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>The pharmacy

</td></tr><tr style="mso-yfti-irow: 8; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Exclusions

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">No exclusions

</td></tr><tr style="mso-yfti-irow: 9; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Exclusion Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">N/A

</td></tr><tr style="mso-yfti-irow: 10; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Numerator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Accessibility of e-care plan by all members of the pharmacy

</td></tr><tr style="mso-yfti-irow: 11; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Numerator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Nominal endpoint determined by survey results

</td></tr><tr style="mso-yfti-irow: 12; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Seguridad Measure Specification Process

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/vOaimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/vOaimage.png)

<span style="mso-no-proof: yes;">  
</span>

</td></tr><tr style="mso-yfti-irow: 13; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Data Stratification

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">The measure rate will be reported as pharmacy.

If available and feasible, measure rate will be reported by type of pharmacy (e.g., health-system, community, specialty, mail-order, long-term care).

If available and feasible, measure rate will be reported by line of business (pharmacy Medicare rate, pharmacy Medicaid rate, pharmacy Commercial rate, and pharmacy uninsured rate).

Risk adjustment will be applied when available.

</td></tr><tr style="mso-yfti-irow: 14; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Value Sets

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">No value set is required for the calculation of this measure.

</td></tr><tr style="mso-yfti-irow: 15; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Future Iterations

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Many pharmacy measures are designed as structure or process. Future goals of this concept include evaluating the outcomes from E-Care Plan submissions, type of data within E-Care Plans, and other aspects of safety/quality.

</td></tr><tr style="mso-yfti-irow: 16; mso-yfti-lastrow: yes; height: 19.55pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="154">Harmonization<sup>1</sup>

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="736">Payors: N/A

Providers: N/A

</td></tr></tbody></table>

1\. Measures that have either the same target populations (denominator) or the same measure focus (numerators) may be considered related, whereas measures that have the same targeted population (denominator) and same measure focus (numerator), are considered competing measures. Measures being developed should be harmonized, where feasible, to previously established measures to decrease measure burden. Choose My Pharmacy measures are developed for pharmacy evaluation, which is a novel area for measurement science, no current measure evaluates this level of analysis. Choose My Pharmacy measures will be harmonized to the extent possible, recognizing different levels of analysis have different data elements, and instead the focus will be to vertically integrate the Choose My Pharmacy measures with other measurement systems and measures.

# Point of Care Testing Structure

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-title-point-of-care-" style="width: 667.25pt; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;" width="890"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Title

</td><td style="width: 551.7pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Point of Care Testing Structure

</td></tr><tr style="mso-yfti-irow: 1; height: 15.7pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 15.7pt;" valign="top" width="154">Description

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 15.7pt;" valign="top" width="736">Possess of a CLIA-waiver in the pharmacy.

A higher score is better

</td></tr><tr style="mso-yfti-irow: 2; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Point-of-care testing (POCT) requires a CLIA-waiver. Pharmacies that offer point-of-care testing may be able to optimize care through patient monitoring (blood glucose, HbA1c, HIV, influenza, COVID-19, pharmacogenomics, lipids, and others).

</td></tr><tr style="mso-yfti-irow: 3; height: 173.2pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="154">Logic Model

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/Q5Qimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/Q5Qimage.png)

<span style="mso-no-proof: yes;">  
</span>

This measure evaluates the pharmacy’s readiness to provide advance services and address gaps in care, healthcare accessibility, and monitoring.

</td></tr><tr style="mso-yfti-irow: 4; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Level of Analysis

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Pharmacy (Nominal and Structure)

</td></tr><tr style="mso-yfti-irow: 5; height: 9.5pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="154">Data Source

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="736">Survey

</td></tr><tr style="mso-yfti-irow: 6; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">This measure is a structure-based measure evaluate a nominal endpoint. The denominator is the pharmacy.

</td></tr><tr style="mso-yfti-irow: 7; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>The pharmacy

</td></tr><tr style="mso-yfti-irow: 8; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Exclusions

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">No exclusions

</td></tr><tr style="mso-yfti-irow: 9; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Exclusion Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">N/A

</td></tr><tr style="mso-yfti-irow: 10; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Numerator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Possession of a CLIA-waiver at the pharmacy

</td></tr><tr style="mso-yfti-irow: 11; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Numerator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Nominal endpoint determined by survey results

</td></tr><tr style="mso-yfti-irow: 12; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Seguridad Measure Specification Process

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/8Pfimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/8Pfimage.png)

<span style="mso-no-proof: yes;">  
</span>

</td></tr><tr style="mso-yfti-irow: 13; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Data Stratification

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">The measure rate will be reported as pharmacy.

If available and feasible, measure rate will be reported by type of pharmacy (e.g., health-system, community, specialty, mail-order, long-term care).

If available and feasible, measure rate will be reported by line of business (pharmacy Medicare rate, pharmacy Medicaid rate, pharmacy Commercial rate, and pharmacy uninsured rate).

Risk adjustment will be applied when available.

</td></tr><tr style="mso-yfti-irow: 14; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Value Sets

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">No value set is required for the calculation of this measure.

</td></tr><tr style="mso-yfti-irow: 15; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Future Iterations

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Many pharmacy measures are designed as structure or process. Future goals of this concept include evaluating the outcomes from CLIA-waived tests, the types of tests, patient-reported outcomes, and other aspects of the quality and safety of POCT.

</td></tr><tr style="mso-yfti-irow: 16; mso-yfti-lastrow: yes; height: 19.55pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="154">Harmonization<sup>1</sup>

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="736">Payors: Some payors are evaluated on collection of clinical data, like hemoglobin A1c. This measure will help pharmacies align with those measures.

Providers: N/A

</td></tr></tbody></table>

1\. Measures that have either the same target populations (denominator) or the same measure focus (numerators) may be considered related, whereas measures that have the same targeted population (denominator) and same measure focus (numerator), are considered competing measures. Measures being developed should be harmonized, where feasible, to previously established measures to decrease measure burden. Choose My Pharmacy measures are developed for pharmacy evaluation, which is a novel area for measurement science, no current measure evaluates this level of analysis. Choose My Pharmacy measures will be harmonized to the extent possible, recognizing different levels of analysis have different data elements, and instead the focus will be to vertically integrate the Choose My Pharmacy measures with other measurement systems and measures.

# Employee Vaccination Rate

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-title-employee-vacci" style="width: 667.25pt; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;" width="890"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Title

</td><td style="width: 551.7pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Employee Vaccination Rate

</td></tr><tr style="mso-yfti-irow: 1; height: 15.7pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 15.7pt;" valign="top" width="154">Description

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 15.7pt;" valign="top" width="736">Percent of employees in a pharmacy that are vaccinated for influenza and COVID-19.

A higher rate is better.

</td></tr><tr style="mso-yfti-irow: 2; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Similar to health systems, pharmacies are frontline workers during pandemics. Ensuring pharmacies are not hot spots of disease will help prevent pandemics.

</td></tr><tr style="mso-yfti-irow: 3; height: 173.2pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="154">Logic Model

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/4rAimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/4rAimage.png)

<span style="mso-no-proof: yes;">  
</span>

This measure evaluates the pharmacy’s role in public health and mitigated infectious diseases. As healthcare providers, pharmacy teams should be immunized as soon as possible to protect themselves, their families, and the public.

</td></tr><tr style="mso-yfti-irow: 4; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Level of Analysis

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Pharmacy (Employee)

</td></tr><tr style="mso-yfti-irow: 5; height: 9.5pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="154">Data Source

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="736">Survey

</td></tr><tr style="mso-yfti-irow: 6; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Number of employees (full or part time) at the pharmacy during a measurement year

</td></tr><tr style="mso-yfti-irow: 7; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>1. Number of part-time employees

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>2. Number of full-time employees

</td></tr><tr style="mso-yfti-irow: 8; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Exclusions

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Exclude any employee &lt;18 years old; any employee that works ≤6 months.

</td></tr><tr style="mso-yfti-irow: 9; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Exclusion Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Minors may need parental permission. All employees are encouraged to receive immunizations. Data show that to reach herd immunity (often defined as 70% immunized), individuals 17 years old and younger will need to be vaccinated. However, most pharmacies will not have ≥30% of staff ≤17 years old.

Employees working ≤6 months may not be employed during the annual influenza immunization period.

</td></tr><tr style="mso-yfti-irow: 10; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Numerator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Number of employees vaccinated with influenza and COVID-19 immunizations

</td></tr><tr style="mso-yfti-irow: 11; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Numerator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Count the number of individuals that have received the COVID-19 and influenza vaccines

</td></tr><tr style="mso-yfti-irow: 12; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Seguridad Measure Specification Process

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/Ybnimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/Ybnimage.png)

<span style="mso-no-proof: yes;">  
</span>

</td></tr><tr style="mso-yfti-irow: 13; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Data Stratification

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">The measure rate will be reported as pharmacy.

If available and feasible, measure rate will be reported by type of pharmacy (e.g., health-system, community, specialty, mail-order, long-term care).

If available and feasible, measure rate will be reported by line of business (pharmacy Medicare rate, pharmacy Medicaid rate, pharmacy Commercial rate, and pharmacy uninsured rate).

Risk adjustment will be applied when available.

</td></tr><tr style="mso-yfti-irow: 14; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Value Sets

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">No value set is required for the calculation of this measure.

</td></tr><tr style="mso-yfti-irow: 15; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Future Iterations

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">If other pandemics or required vaccines are authorized/approved, this measure would be updated.

</td></tr><tr style="mso-yfti-irow: 16; mso-yfti-lastrow: yes; height: 19.55pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="154">Harmonization<sup>1</sup>

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="736">Payors: N/A

Providers: This measure is similar to the CMS Hospital Compare Employee Vaccination rate measure.

</td></tr></tbody></table>

1\. Measures that have either the same target populations (denominator) or the same measure focus (numerators) may be considered related, whereas measures that have the same targeted population (denominator) and same measure focus (numerator), are considered competing measures. Measures being developed should be harmonized, where feasible, to previously established measures to decrease measure burden. Choose My Pharmacy measures are developed for pharmacy evaluation, which is a novel area for measurement science, no current measure evaluates this level of analysis. Choose My Pharmacy measures will be harmonized to the extent possible, recognizing different levels of analysis have different data elements, and instead the focus will be to vertically integrate the Choose My Pharmacy measures with other measurement systems and measures.

# Advanced Pharmacy Technicians

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-title-advanced-pharm" style="width: 667.25pt; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;" width="890"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Title

</td><td style="width: 551.7pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Advanced Pharmacy Technicians

</td></tr><tr style="mso-yfti-irow: 1; height: 15.7pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 15.7pt;" valign="top" width="154">Description

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 15.7pt;" valign="top" width="736">Percent of pharmacy technicians with advance training

</td></tr><tr style="mso-yfti-irow: 2; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Pharmacy technicians are able to expand scope of practice through certifications and credentials. The elevated pharmacy technician provides higher quality care and allows the pharmacy staff to focus on non-dispensing clinical activities.

</td></tr><tr style="mso-yfti-irow: 3; height: 173.2pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="154">Logic Model

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/VKvimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/VKvimage.png)

<span style="mso-no-proof: yes;">  
</span>

This measure evaluates the training and credentialing of a pharmacy technician. When pharmacy technicians are able to advance scope of practice, like product verification, pharmacists are able to advance their role towards medication optimization.

</td></tr><tr style="mso-yfti-irow: 4; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Level of Analysis

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Pharmacy (Employee)

</td></tr><tr style="mso-yfti-irow: 5; height: 9.5pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="154">Data Source

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="736">Survey

</td></tr><tr style="mso-yfti-irow: 6; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Number of pharmacy technicians (full or part time) at the pharmacy during a measurement year

</td></tr><tr style="mso-yfti-irow: 7; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>1. Number of part-time pharmacy technicians

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>2. Number of full-time pharmacy technicians

</td></tr><tr style="mso-yfti-irow: 8; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Exclusions

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Exclude any employee ≤17 years old, less than 6 months employment, or ≤1 year as a pharmacy technician

</td></tr><tr style="mso-yfti-irow: 9; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Exclusion Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Minors may need parental permission, other technicians may not be eligible for technician exam

</td></tr><tr style="mso-yfti-irow: 10; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Numerator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Number of pharmacy technicians with advance credentials and training

</td></tr><tr style="mso-yfti-irow: 11; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Numerator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman';"><span style="mso-list: Ignore;">•<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Count the number of individuals that have advanced training.

</td></tr><tr style="mso-yfti-irow: 12; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Seguridad Measure Specification Process

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/26uimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/26uimage.png)

<span style="mso-no-proof: yes;">  
</span>

</td></tr><tr style="mso-yfti-irow: 13; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Data Stratification

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">The measure rate will be reported as pharmacy.

If available and feasible, measure rate will be reported by type of pharmacy (e.g., health-system, community, specialty, mail-order, long-term care).

If available and feasible, measure rate will be reported by line of business (pharmacy Medicare rate, pharmacy Medicaid rate, pharmacy Commercial rate, and pharmacy uninsured rate).

Risk adjustment will be applied when available.

</td></tr><tr style="mso-yfti-irow: 14; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Value Sets

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">No value set is required for the calculation of this measure.

</td></tr><tr style="mso-yfti-irow: 15; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Future Iterations

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">As additional training programs and certificates are authorized for pharmacy technicians, the numerator will be updated.

</td></tr><tr style="mso-yfti-irow: 16; mso-yfti-lastrow: yes; height: 19.55pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="154">Harmonization<sup>1</sup>

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="736">Payors: N/A

Providers: N/A

</td></tr></tbody></table>

1\. Measures that have either the same target populations (denominator) or the same measure focus (numerators) may be considered related, whereas measures that have the same targeted population (denominator) and same measure focus (numerator), are considered competing measures. Measures being developed should be harmonized, where feasible, to previously established measures to decrease measure burden. Choose My Pharmacy measures are developed for pharmacy evaluation, which is a novel area for measurement science, no current measure evaluates this level of analysis. Choose My Pharmacy measures will be harmonized to the extent possible, recognizing different levels of analysis have different data elements, and instead the focus will be to vertically integrate the Choose My Pharmacy measures with other measurement systems and measures.

# Improving Pain Management Safety

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-title-improving-pain" style="width: 667.25pt; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;" width="890"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 10.0pt;"><td style="width: 146.05px; border: 1pt solid windowtext; padding: 0in 5.4pt; height: 10pt;" valign="top" width="154">Title

</td><td style="width: 743.594px; border-top: 1pt solid windowtext; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-image: initial; border-left: none; padding: 0in 5.4pt; height: 10pt;" valign="top" width="736"><span style="font-size: 11.0pt;">Improving Pain Management Safety</span>

</td></tr><tr style="mso-yfti-irow: 1; height: 40.15pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 40.15pt;" valign="top" width="154">Description

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 40.15pt;" valign="top" width="736">Percent of households where at least one individual is at risk for adverse opioid event, like overdose or respiratory depression, with naloxone available.

A higher score is better

</td></tr><tr style="mso-yfti-irow: 2; height: 30.1pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Rationale

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Many individuals are at increased risk for adverse events associated with opioid use. Additionally, many states have implemented standing protocols for naloxone dispensing without prescription to patients or caregivers of patients at risk for adverse opioid events. This measure ensures, at a household level, naloxone is available to any patient.

</td></tr><tr style="mso-yfti-irow: 3; height: 173.2pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 173.2pt;" valign="top" width="154">Logic Model

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 173.2pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/ibHimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/ibHimage.png)

<span style="mso-no-proof: yes;">  
</span>

This measure ensures any household at risk for adverse opioid events is evaluated and provided treatment.

</td></tr><tr style="mso-yfti-irow: 4; height: 10.0pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 10pt;" valign="top" width="154">Level of Analysis

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 10pt;" valign="top" width="736">Pharmacy (Patient)

</td></tr><tr style="mso-yfti-irow: 5; height: 9.5pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 9.5pt;" valign="top" width="154">Data Source

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 9.5pt;" valign="top" width="736">Pharmacy Data

</td></tr><tr style="mso-yfti-irow: 6; height: 20.05pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Statement

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Any household with a patient at risk for adverse opioid event defined as patients prescribed opioids and any of the following:

- <span style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>≥50 morphine milligram equivalents per day
- <span style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Concomitant use of sedating medications, like benzodiazepines

</td></tr><tr style="mso-yfti-irow: 7; height: 30.1pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Calculation

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>1. All individuals in the pharmacy

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>2. All individuals prescribed an opioid

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>3. All individuals with risk factor (≥50 MME or benzodiazepine)

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>4. Exclude non-human patients

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">5.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>5. Identify each unique household

</td></tr><tr style="mso-yfti-irow: 8; height: 20.05pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Exclusions

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Any non-human patients (e.g., cats, dogs, clinics, office-use, etc)

</td></tr><tr style="mso-yfti-irow: 9; height: 30.1pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Exclusion Rationale

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Pharmacies may provide care to pets or other veterinarian needs, or for office-use. This patient profiles should be excluded from the measure calculation.

</td></tr><tr style="mso-yfti-irow: 10; height: 20.05pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Numerator Statement

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Household from the denominator with a naloxone dispensed during the measurement year

</td></tr><tr style="mso-yfti-irow: 11; height: 30.1pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Numerator Calculation

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>1. Identify all naloxone prescriptions dispensed from the pharmacy

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>2. Identify each household with a naloxone prescription

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>3. Households that have a match in the denominator are in the numerator.

</td></tr><tr style="mso-yfti-irow: 12; height: 30.1pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Seguridad Measure Specification Process

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 30.1pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/F2jimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/F2jimage.png)

<span style="mso-no-proof: yes;">  
</span>

</td></tr><tr style="mso-yfti-irow: 13; height: 30.1pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Data Stratification

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 30.1pt;" valign="top" width="736">The measure rate will be reported as a percent of patients within a single pharmacy.

If available and feasible, measure rate will be reported by type of pharmacy (e.g., health-system, community, specialty, mail-order, long-term care).

If available and feasible, measure rate will be reported by line of business (pharmacy Medicare rate, pharmacy Medicaid rate, pharmacy Commercial rate, and pharmacy uninsured rate).

Risk adjustment will be applied when available.

</td></tr><tr style="mso-yfti-irow: 14; height: 10.0pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 10pt;" valign="top" width="154">Value Sets

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 10pt;" valign="top" width="736">The value set *Seguridad – Opioids* and *Seguridad – Opioid Risk Medications* will be used to support the exclusion criteria.

</td></tr><tr style="mso-yfti-irow: 15; height: 10.0pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 10pt;" valign="top" width="154">Future Iterations

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 10pt;" valign="top" width="736">Many pharmacy measures are designed as structure or process. Future goals of this concept include measures focused on appropriate dosing based on renal function and assessment of all patients.

</td></tr><tr style="mso-yfti-irow: 16; mso-yfti-lastrow: yes; height: 19.55pt;"><td style="width: 146.05px; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; border-left: 1pt solid windowtext; border-image: initial; border-top: none; padding: 0in 5.4pt; height: 19.55pt;" valign="top" width="154">Harmonization<sup>1</sup>

</td><td style="width: 743.594px; border-top: none; border-left: none; border-bottom: 1pt solid windowtext; border-right: 1pt solid windowtext; padding: 0in 5.4pt; height: 19.55pt;" valign="top" width="736">Payors: PQA’s Opioid Measure Set

Providers: PQA’s Opioid Measure Set

</td></tr></tbody></table>

1\. Measures that have either the same target populations (denominator) or the same measure focus (numerators) may be considered related, whereas measures that have the same targeted population (denominator) and same measure focus (numerator), are considered competing measures. Measures being developed should be harmonized, where feasible, to previously established measures to decrease measure burden. Choose My Pharmacy measures are developed for pharmacy evaluation, which is a novel area for measurement science, no current measure evaluates this level of analysis. Choose My Pharmacy measures will be harmonized to the extent possible, recognizing different levels of analysis have different data elements, and instead the focus will be to vertically integrate the Choose My Pharmacy measures with other measurement systems and measures.

# Improving Diabetes Safety

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-title-improving-diab" style="width: 667.25pt; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;" width="890"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Title

</td><td style="width: 551.7pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736"><span style="font-size: 11.0pt;">Improving Diabetes Safety</span>

</td></tr><tr style="mso-yfti-irow: 1; height: 40.15pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 40.15pt;" valign="top" width="154">Description

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 40.15pt;" valign="top" width="736">Percent of patients at risk for glycemia receiving bolus insulin receive glucagon.

A higher score is better

</td></tr><tr style="mso-yfti-irow: 2; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Many patients with diabetes are at risk for hypoglycemia, which can cause hospitalizations or death. Individuals using insulin, particularly meal-time, or bolus, are at increased risk for hypoglycemia.

</td></tr><tr style="mso-yfti-irow: 3; height: 173.2pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="154">Logic Model

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/MsJimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/MsJimage.png)

<span style="mso-no-proof: yes;">  
</span>

This measure ensures patients at increased risk for hypoglycemia have appropriate treatment available.

</td></tr><tr style="mso-yfti-irow: 4; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Level of Analysis

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Pharmacy (Patient)

</td></tr><tr style="mso-yfti-irow: 5; height: 9.5pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="154">Data Source

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="736">Pharmacy Data

</td></tr><tr style="mso-yfti-irow: 6; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Patient at risk for hypoglycemia due to bolus insulin use.

</td></tr><tr style="mso-yfti-irow: 7; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>1. All individuals in the pharmacy

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>2. All individuals prescribed a bolus insulin

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>3. Exclude non-human patients.

</td></tr><tr style="mso-yfti-irow: 8; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Exclusions

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Any non-human patients (e.g., cats, dogs, clinics, office-use, etc)

</td></tr><tr style="mso-yfti-irow: 9; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Exclusion Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Pharmacies may provide care to pets or other veterinarian needs, or for office-use. This patient profiles should be excluded from the measure calculation.

</td></tr><tr style="mso-yfti-irow: 10; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Numerator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Patients from the denominator with glucagon.

</td></tr><tr style="mso-yfti-irow: 11; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Numerator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Identify individuals from the denominator with a prescription for glucagon

</td></tr><tr style="mso-yfti-irow: 12; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Seguridad Measure Specification Process

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/vBjimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/vBjimage.png)

<span style="mso-no-proof: yes;">  
</span>

</td></tr><tr style="mso-yfti-irow: 13; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Data Stratification

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">The measure rate will be reported as a percent of patients within a single pharmacy.

If available and feasible, measure rate will be reported by type of pharmacy (e.g., health-system, community, specialty, mail-order, long-term care).

If available and feasible, measure rate will be reported by line of business (pharmacy Medicare rate, pharmacy Medicaid rate, pharmacy Commercial rate, and pharmacy uninsured rate).

Risk adjustment will be applied when available.

</td></tr><tr style="mso-yfti-irow: 14; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Value Sets

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">The value set *Seguridad – Basal Insulin* will be used to support the exclusion criteria.

</td></tr><tr style="mso-yfti-irow: 15; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Future Iterations

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Many pharmacy measures are designed as structure or process. Future goals of this concept include measures will include other high-risk diabetes medications.

</td></tr><tr style="mso-yfti-irow: 16; mso-yfti-lastrow: yes; height: 19.55pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="154">Harmonization<sup>1</sup>

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="736">Payors: N/A

Providers: N/A

</td></tr></tbody></table>

1\. Measures that have either the same target populations (denominator) or the same measure focus (numerators) may be considered related, whereas measures that have the same targeted population (denominator) and same measure focus (numerator), are considered competing measures. Measures being developed should be harmonized, where feasible, to previously established measures to decrease measure burden. Choose My Pharmacy measures are developed for pharmacy evaluation, which is a novel area for measurement science, no current measure evaluates this level of analysis. Choose My Pharmacy measures will be harmonized to the extent possible, recognizing different levels of analysis have different data elements, and instead the focus will be to vertically integrate the Choose My Pharmacy measures with other measurement systems and measures.

# Identifying Social Determinants of Health

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-title-identifying-so" style="width: 667.25pt; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;" width="890"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154"><span style="font-size: 8.0pt; font-family: 'Calibri',sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">  
</span>Title

</td><td style="width: 551.7pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736"><span style="font-size: 11.0pt;">Identifying Social Determinants of Health</span>

</td></tr><tr style="mso-yfti-irow: 1; height: 40.15pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 40.15pt;" valign="top" width="154">Description

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 40.15pt;" valign="top" width="736">Percent of patients in the pharmacy that have documented SDOH data elements.

A higher score is better

</td></tr><tr style="mso-yfti-irow: 2; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Pharmacies are often identifying and resolving social determinant of health barriers for patients. However, documentation is vital to showing progress on care. This measure evaluates if a pharmacy is collecting SDOH identifiers at the pharmacy. Once patients are identified, pharmacies will be able to make interventions and bill for these services.

</td></tr><tr style="mso-yfti-irow: 3; height: 173.2pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="154">Logic Model

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/GhPimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/GhPimage.png)

<span style="mso-no-proof: yes;">  
</span>

This measure ensures pharmacies are documenting and collecting the data required for SDOH clinical services.

</td></tr><tr style="mso-yfti-irow: 4; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Level of Analysis

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Pharmacy (Patient)

</td></tr><tr style="mso-yfti-irow: 5; height: 9.5pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="154">Data Source

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="736">Pharmacy Data

</td></tr><tr style="mso-yfti-irow: 6; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">All patients within a pharmacy

</td></tr><tr style="mso-yfti-irow: 7; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>1. Identify all prescriptions in a measurement year

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>2. Identify all unique patients from the prescriptions

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>3. Apply exclusions

</td></tr><tr style="mso-yfti-irow: 8; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Exclusions

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Any non-human patients (e.g., cats, dogs, clinics, office-use, etc)

</td></tr><tr style="mso-yfti-irow: 9; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Exclusion Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Pharmacies may provide care to pets or other veterinarian needs, or for office-use. This patient profiles should be excluded from the measure calculation.

</td></tr><tr style="mso-yfti-irow: 10; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Numerator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Patients from the denominator with documented SDOH data elements, including: Insurance Status, Education level, Race, Ethnicity, Zip Code

</td></tr><tr style="mso-yfti-irow: 11; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Numerator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Identify individuals from the denominator with a documented SDOH data element (composite)

</td></tr><tr style="mso-yfti-irow: 12; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Seguridad Measure Specification Process

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/RcVimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/RcVimage.png)

<span style="mso-no-proof: yes;">  
</span>

</td></tr><tr style="mso-yfti-irow: 13; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Data Stratification

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">The measure rate will be reported as a percent of patients within a single pharmacy.

If available and feasible, measure rate will be reported by type of pharmacy (e.g., health-system, community, specialty, mail-order, long-term care).

If available and feasible, measure rate will be reported by line of business (pharmacy Medicare rate, pharmacy Medicaid rate, pharmacy Commercial rate, and pharmacy uninsured rate).

Risk adjustment will be applied when available.

</td></tr><tr style="mso-yfti-irow: 14; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Value Sets

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">No value set is required for this measure.

</td></tr><tr style="mso-yfti-irow: 15; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Future Iterations

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Many pharmacy measures are designed as structure or process. Future goals of this measure will be to track additional SDOH data elements, like housing or food insecurity, for eventual Z-code billing and interventions.

</td></tr><tr style="mso-yfti-irow: 16; mso-yfti-lastrow: yes; height: 19.55pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="154">Harmonization<sup>1</sup>

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="736">Payors: N/A

Providers: N/A

</td></tr></tbody></table>

1\. Measures that have either the same target populations (denominator) or the same measure focus (numerators) may be considered related, whereas measures that have the same targeted population (denominator) and same measure focus (numerator), are considered competing measures. Measures being developed should be harmonized, where feasible, to previously established measures to decrease measure burden. Choose My Pharmacy measures are developed for pharmacy evaluation, which is a novel area for measurement science, no current measure evaluates this level of analysis. Choose My Pharmacy measures will be harmonized to the extent possible, recognizing different levels of analysis have different data elements, and instead the focus will be to vertically integrate the Choose My Pharmacy measures with other measurement systems and measures.

# Chapter 5: Choose My Pharmacy® PMS Support



# PioneerRx

**Prescription Report**

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Go to the **Rx** tab

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Select the **binocular icon** in the Data Entry section

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>In the **Completed Between** line, enter the date range

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Press **Search (F12)** to generate the report

Once the report has been generated, create a new report design layout.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>In the drop-down box next to View, select **Expanded with Comments**

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Select the **Field Chooser icon** [![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/S9Bimage.png) o](https://docs.rxsafety.io/uploads/images/gallery/2023-08/S9Bimage.png)n the left side of the screen

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Check the boxes of the data fields you want to report

<div align="center" id="bkmrk-pioneerrx-date-fille"><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="width: 326px; border-collapse: collapse;" width="206"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206">**<span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">PioneerRx</span>**

</td></tr><tr style="mso-yfti-irow: 1; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Date Filled</span>

</td></tr><tr style="mso-yfti-irow: 2; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Days Supply</span>

</td></tr><tr style="mso-yfti-irow: 3; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Dispensed Item Name</span>

</td></tr><tr style="mso-yfti-irow: 4; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Dispensed Item NDC</span>

</td></tr><tr style="mso-yfti-irow: 5; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Dispensed Item Strength</span>

</td></tr><tr style="mso-yfti-irow: 6; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Dispensed Quantity</span>

</td></tr><tr style="mso-yfti-irow: 7; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Origin</span>

</td></tr><tr style="mso-yfti-irow: 8; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Patient Age</span>

</td></tr><tr style="mso-yfti-irow: 10; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Patient Ethnicity</span>

</td></tr><tr style="mso-yfti-irow: 11; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Patient Gender</span>

</td></tr><tr style="mso-yfti-irow: 12; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Patient Paid Amount</span>

</td></tr><tr style="mso-yfti-irow: 13; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Patient Primary Address</span>

</td></tr><tr><td style="width: 325px; padding: 0in 5.4pt;"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Patient Primary Zip Code  
</span>

</td></tr><tr style="mso-yfti-irow: 14; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Patient Race</span>

</td></tr><tr style="mso-yfti-irow: 15; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Patient Serial Number/Patient Central ID  
</span>

</td></tr><tr style="mso-yfti-irow: 16; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Pharmacy NCPDP</span>

</td></tr><tr style="mso-yfti-irow: 17; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Primary ICD10 Code</span>

</td></tr><tr style="mso-yfti-irow: 18; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Primary ICD10 Code Description</span>

</td></tr><tr style="mso-yfti-irow: 19; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Refill Number</span>

</td></tr><tr style="mso-yfti-irow: 20; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Rx Number</span>

</td></tr><tr style="mso-yfti-irow: 21; mso-yfti-lastrow: yes; height: 16.0pt;"><td nowrap="nowrap" style="width: 325px; padding: 0in 5.4pt; height: 16pt;" valign="bottom" width="206"><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: 'Times New Roman'; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; color: black;">Sig Code</span>

</td></tr></tbody></table>

</div><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Select the **blue plus sign** next to the View drop-down box

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">5.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Name the layout

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">6.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Press **Search (F12)** to regenerate the report with new data fields

Export the report to an excel file.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Select **Menu** in the top right corner of the green results box.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Choose **Export to Excel**

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Name and save Excel document

**Patient Weight &amp; Allergy Report**

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Go to **Patient** tab

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Select the **binocular icon** in the Patient section

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>In the **Activity Between**, enter the same date range used to generate the prescription report

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Press **Search (F12)** to generate the report

Once the report has been generated, use the steps to create a new report design layout from above that includes **Serial Number, Weight, and Allergies** and regenerate the report.

Export, name, and save the report as an Excel document.

**Patient Serum Creatinine Report**

<span style="text-decoration: underline;">**\*\*If your pharmacy does not collect serum creatinine, there is no need to submit a report\*\***</span>

Create a patient category.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Go to the **System** tab

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Select the **Category icon**

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>In the Category Scope drop-down box, select **Patient**

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Press the **green plus sign** on the right side to create a new category

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">5.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Provide a name and description for the category

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">6.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Choose **Auto** in the Type drop-down

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">7.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>In **box B (Any of These)**, press the **green plus sign**

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">8.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Choose **Any Lab Greater Than** as a filter

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">9.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Choose **Comprehensive Metabolic Panel – Creatinine, Serum (SCr)** as the lab

E. Enter 0 in the **Greater Than** box

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">P. </span></span>Press **Save (F12)**

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.. <span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Make sure the status of the category is **active** and press **Save (F12)**

You must process the category for it to immediately work, or it will not become active until the next day.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">.1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Select the **Actions** drop in the top right

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Choose **Process Category Auto Filter Rules** and follow the prompts

Use the patient category to generate a patient report

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">...<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Go to **Patient** tab

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Select the **binocular icon** in the Patient section

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>In the **Activity Between** line, enter the same date range used to generate the prescription report

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>From the **Category** drop-down, select the patient category.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">5.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Press **Search (F12)**

This will generate a report of all the patients in your system with a SCr value on file. Choose or create a layout that includes the Serial Number. Export the report to an Excel document.

# ComputerRx

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Create a view for your data.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">a)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>You’ll first want to create a “view” including all of the data-points you want, and none of the data-points you don’t want. Run a very limited dispense report (like filled today) by navigating to Reports&gt;Dispensing Report&gt;Detailed Dispensing.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">i.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>ComputerRx will pull up your dispense report with your default view.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">ii.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>In the top right of the screen, Press the blue + sign next to the view dropdown to create a new “view” - name it something like “Seguridad”

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">iii.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Customize the view to match the data request, generally as follows:

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Include columns (these are the specific data element names in ComputerRx):

- Patient Record (please be sure you are selecting Patient **Record** and *not* Patient **ID**, as they are different)
- Date
- Drug
- NDC
- Patient Age
- Diag. Code 1
- Rx Origin
- Day Supply
- Quan.
- Sig
- Patient Address
- Patient Zip
- Sex
- Race
- Ethnicity

<span style="mso-spacerun: yes;"> </span>

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Additional data elements *that may not be available for download. Please find the closest match if possible*:

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Patient Allergies

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Patient Serum Creatinine

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Species

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Patient Weight

5\. ICD-10 Description

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>You may need a few more or a few less columns depending on the specific data request.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">iv.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Save the “view” as you have it set by clicking the Save button (floppy disk).

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Pull the data requested

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">a)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Put in filters for the specific request. For example:

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">i.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>In Start Date, put 1/1/2021, and End Date put 3/30/2021. (Quarterly results aid in data pull)

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">ii.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>The report will build (it may take some time).

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">b)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Once the report has loaded and been filtered, press export at the bottom middle left of the screen to generate an excel file.

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">c)<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Name the excel appropriately per the work order, for example “Seguridad NABP DATE”.

# Liberty

<span style="text-decoration: underline;">**Generating Reports for Liberty**</span>

<div class="page" id="bkmrk-select-%E2%80%9Creporting%E2%80%9D-o" title="Page 48"><div class="page" title="Page 48"><div class="layoutArea"><div class="column">1. Select “Reporting” on the top
2. Select “Rx Data”
3. Right Click Top Row on the pop up box
4. Select "Column Chooser”
5. Add requested Seguridad Data Elements

</div></div></div></div>- Customer ID
- Date Dispensed
- Drug Name
- Drug NDC
- Customer Age
- ICD Code
- ICD10 Description
- Origin Code
- Customer Allergies
- Customer Weight
- Customer SrCr
- Day Supply
- Qty
- Sigs
- Customer Address
- Customer Zip
- Customer Species
- Customer Gender
- Customer Race
- Customer Ethnicity

<div class="page" id="bkmrk-use-%E2%80%98advance%E2%80%99-to-upd" title="Page 48"><div class="layoutArea"><div class="column">1. Use ‘Advance’ to update the time range
2. Save As Excel on Desktop

</div></div></div>

# Rx30

<table border="1" id="bkmrk-general-field-name-r" style="border-collapse: collapse; width: 82.2222%; border-width: 2px;"><colgroup><col style="width: 46.684%;"></col><col style="width: 53.316%;"></col></colgroup><tbody><tr><td style="border-width: 2px;"><span style="text-decoration: underline;">**General Field Name**</span>  
</td><td style="border-width: 2px;"><span style="text-decoration: underline;">**Rx30 Field Name**</span>  
</td></tr><tr><td style="border-width: 2px;">Date Dispensed  
</td><td style="border-width: 2px;">FILLDATE</td></tr><tr><td style="border-width: 2px;">Patient Date of Birth  
</td><td style="border-width: 2px;">PATDOB</td></tr><tr><td style="border-width: 2px;">Directions  
</td><td style="border-width: 2px;">DIRECTION 1</td></tr><tr><td style="border-width: 2px;">Directions  
</td><td style="border-width: 2px;">DIRECTION 2</td></tr><tr><td style="border-width: 2px;">Directions  
</td><td style="border-width: 2px;">DIRECTION 3</td></tr><tr><td style="border-width: 2px;">Directions  
</td><td style="border-width: 2px;">DIRECTION 4</td></tr><tr><td style="border-width: 2px;">Directions  
</td><td style="border-width: 2px;">DIRECTION 5</td></tr><tr><td style="border-width: 2px;">Gender  
</td><td style="border-width: 2px;">GENDER</td></tr><tr><td style="border-width: 2px;">Patient Address/Household  
</td><td style="border-width: 2px;">PATADD1</td></tr><tr><td style="border-width: 2px;">Patient Address/Household</td><td style="border-width: 2px;">PATADD2</td></tr><tr><td style="border-width: 2px;">Insurance Status  
</td><td style="border-width: 2px;">PAYTYPE</td></tr><tr><td style="border-width: 2px;">Medication Days Supply  
</td><td style="border-width: 2px;">DS</td></tr><tr><td style="border-width: 2px;"><div class="ewa-rteLine">Medication Indication ICD10</div></td><td style="border-width: 2px;">RXDIAG 1</td></tr><tr><td style="border-width: 2px;">Medication Name  
</td><td style="border-width: 2px;">DRUG NAME</td></tr><tr><td style="border-width: 2px;">Medication Origin  
</td><td style="border-width: 2px;">RXORIGIN</td></tr><tr><td style="border-width: 2px;">NDC  
</td><td style="border-width: 2px;">NDC</td></tr><tr><td style="border-width: 2px;">Patient ID  
</td><td style="border-width: 2px;">PATKEY</td></tr><tr><td style="border-width: 2px;">Prescription Number  
</td><td style="border-width: 2px;">RXNBR</td></tr><tr><td style="border-width: 2px;">Quantity Dispensed  
</td><td style="border-width: 2px;">QTY DSP</td></tr><tr><td style="border-width: 2px;">Patient Zip Code  
</td><td style="border-width: 2px;">PATZIP</td></tr></tbody></table>

# QS/1

QS/1 support is currently unavailable at this time. Please submit your data as best you can using the following generic terms to guide you. Depending on the pharmacy management system, reports may be a single file with all data elements or may be multiple files. Please generate your Seguridad Data Reports from the pharmacy management system and submit the data as **xls**, **xlsx**, or **csv**.

- De-identified Patient ID (patient serial number, customer ID, patient record)
- Date Dispensed
- Drug Name
- Drug NDC
- Customer Age (patient age)
- ICD-10 Code
- ICD-10 Description
- Origin Code (prescription origin status, walk-in, electronic, telephone)
- Patient Allergies
- Patient Weight
- Patient Serum Creatinine
- Days Supply
- Quantity Dispensed
- Sig/Directions
- Patient Address
- Patient Zip Code
- Patient Species (Human, Cat, Dog)
- Gender
- Race (White, Black, Asian, etc)
- Ethnicity (Hispanic, Non-hispanic)

If you are unable to pull a specific data field - that is ok. Some pharmacy management systems do not report or save all data elements. Pharmacy performance may be lower in some measures, but Seguridad will work with the pharmacy management system to make this a reportable data element in the future.

Once you have submitted your data, please reach out to support@choosemypharmacy.com stating your pharmacy's NCPDP number and which PMS you submitted data from. A member of our team will reach back out to your with further information.

# MicroMerchant

MicroMerchant support is currently unavailable at this time. Please submit your data as best you can using the following generic terms to guide you. Depending on the pharmacy management system, reports may be a single file with all data elements or may be multiple files. Please generate your Seguridad Data Reports from the pharmacy management system and submit the data as **xls**, **xlsx**, or **csv**.

- De-identified Patient ID (patient serial number, customer ID, patient record)
- Date Dispensed
- Drug Name
- Drug NDC
- Customer Age (patient age)
- ICD-10 Code
- ICD-10 Description
- Origin Code (prescription origin status, walk-in, electronic, telephone)
- Patient Allergies
- Patient Weight
- Patient Serum Creatinine
- Days Supply
- Quantity Dispensed
- Sig/Directions
- Patient Address
- Patient Zip Code
- Patient Species (Human, Cat, Dog)
- Gender
- Race (White, Black, Asian, etc)
- Ethnicity (Hispanic, Non-hispanic)

If you are unable to pull a specific data field - that is ok. Some pharmacy management systems do not report or save all data elements. Pharmacy performance may be lower in some measures, but Seguridad will work with the pharmacy management system to make this a reportable data element in the future.

Once you have submitted your data, please reach out to support@choosemypharmacy.com stating your pharmacy's NCPDP number and which PMS you submitted data from. A member of our team will reach back out to your with further information.

# BestRx

BestRx support is currently unavailable at this time. Please submit your data as best you can using the following generic terms to guide you. Depending on the pharmacy management system, reports may be a single file with all data elements or may be multiple files. Please generate your Seguridad Data Reports from the pharmacy management system and submit the data as **xls**, **xlsx**, or **csv**.

- De-identified Patient ID (patient serial number, customer ID, patient record)
- Date Dispensed
- Drug Name
- Drug NDC
- Customer Age (patient age)
- ICD-10 Code
- ICD-10 Description
- Origin Code (prescription origin status, walk-in, electronic, telephone)
- Patient Allergies
- Patient Weight
- Patient Serum Creatinine
- Days Supply
- Quantity Dispensed
- Sig/Directions
- Patient Address
- Patient Zip Code
- Patient Species (Human, Cat, Dog)
- Gender
- Race (White, Black, Asian, etc)
- Ethnicity (Hispanic, Non-hispanic)

If you are unable to pull a specific data field - that is ok. Some pharmacy management systems do not report or save all data elements. Pharmacy performance may be lower in some measures, but Seguridad will work with the pharmacy management system to make this a reportable data element in the future.

Once you have submitted your data, please reach out to support@choosemypharmacy.com stating your pharmacy's NCPDP number and which PMS you submitted data from. A member of our team will reach back out to your with further information.

# FSI Foundation Systems

FSI Foundation Systems support is currently unavailable at this time. Please submit your data as best you can using the following generic terms to guide you. Depending on the pharmacy management system, reports may be a single file with all data elements or may be multiple files. Please generate your Seguridad Data Reports from the pharmacy management system and submit the data as **xls**, **xlsx**, or **csv**.

- De-identified Patient ID (patient serial number, customer ID, patient record)
- Date Dispensed
- Drug Name
- Drug NDC
- Customer Age (patient age)
- ICD-10 Code
- ICD-10 Description
- Origin Code (prescription origin status, walk-in, electronic, telephone)
- Patient Allergies
- Patient Weight
- Patient Serum Creatinine
- Days Supply
- Quantity Dispensed
- Sig/Directions
- Patient Address
- Patient Zip Code
- Patient Species (Human, Cat, Dog)
- Gender
- Race (White, Black, Asian, etc)
- Ethnicity (Hispanic, Non-hispanic)

If you are unable to pull a specific data field - that is ok. Some pharmacy management systems do not report or save all data elements. Pharmacy performance may be lower in some measures, but Seguridad will work with the pharmacy management system to make this a reportable data element in the future.

Once you have submitted your data, please reach out to support@choosemypharmacy.com stating your pharmacy's NCPDP number and which PMS you submitted data from. A member of our team will reach back out to your with further information.

# Chapter 6: Choose My Pharmacy® Report Card FAQs

**I submitted my data! When can I expect my report card?**

Approximately six weeks after the quarterly data request emails are sent out (these are sent on the 1st of the month or first business day at the start of a new quarter). The time between the email being sent out and you receiving your report is spent gathering data from as many of our participating pharmacies as possible as well as engaging in quality assurance to make sure the data is accurate.

**I am going through the onboarding process and submitted my data but never received my Employee Survey. What happen?**

This likely means there was an issue with processing your data submission. If someone from our support team has not reached out to you already, please email <support@choosemypharmacy.com> and include your pharmacy's NCPDP.

**I have a measure rating that says N/A. How can I fix this to 'meet the requirements'?**

N/A, or not applicable, means that the data provided does not allow for a denominator to be calculated for the specified measure. The reasoning can vary from measure to measure. For example, if a pharmacy does not have any patients &lt;18 years old, the *Assessment of Weights in Pediatrics* score would be N/A.

**My entire report card has N/D listed for all measures. What does this mean?**

This means there was most likely an issue with processing your data submission. Be it missing required fields or a formatting error or a technical bug on our end. Please email <support@choosemypharmacy.com> with your pharmacy's NCPDP and our team will be able to identify the error and possibly have you resubmit data to resolve the issue.

**How are each of these metrics measured? How do I go about improving my score?**

For a detailed explanation of how we calculate our metrics, click to view our [Measure Specifications Guide](https://docs.rxsafety.io/books/seguridad-health-measures-implementation-guide/chapter/chapter-4-choose-my-pharmacy-measure-specifications). We have also provided a chart below that shows which collected data points go into the calculation of each measure.

[![Screenshot 2024-06-28 at 10.25.51 AM.png](https://docs.rxsafety.io/uploads/images/gallery/2024-06/scaled-1680-/screenshot-2024-06-28-at-10-25-51-am.png)](https://docs.rxsafety.io/uploads/images/gallery/2024-06/screenshot-2024-06-28-at-10-25-51-am.png)

**My overall score in my report card is blank. Why is it missing?**

Given that our company is still in the early stages of collecting and analyzing data from all of our participating pharmacies, it is difficult to calculate a grade that accurately reflects overall performance at this time. As we gather more data and are able to compare it to previous quarters, we will be able to create an accurate system for calculating grades. Until such a time, we have decided to leave the overall scores blank to avoid confusion.

**My rating for *Known Allergy Status* seems unusually low even though we ask our customers for any allergies. What is causing this?**

The numerator for the measure is calculated by the documentation of any allergies OR no known allergies. Leaving the field blank rather than recording it as "no known allergies" negatively impacts the pharmacy's score. We recommend filling out the allergy status field every time to improve this measure rating.

**Why is Employee Vaccination Rate is reading N/A even though our pharmacy completed the employee surveys?**

As of right now, our engineering team is working through a bug in the calculation that provides an accurate rating for this measurement.